Stay updated on Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page revision/version label was updated from v3.5.2 to v3.5.3 without any visible change to the study details themselves.
    Difference
    0.0%
    Check dated 2026-04-24T16:45:35.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; no visible changes to study details.
    Difference
    0.0%
    Check dated 2026-04-17T13:55:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Two keywords were added to the study's keyword list: Small cell lung carcinoma and Cutaneous neuroendocrine carcinoma.
    Difference
    0.1%
    Check dated 2026-04-03T05:46:28.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a keyword and updated the site revision to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:41:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:12:34.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added the disease keyword Gastric cancer and updated the page revision from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T02:11:13.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.